AstraZeneca Breast Cancer Drug Fails Late-Stage Trial Goal

3-line summary

• AstraZeneca's breast cancer drug failed its late-stage trial goal, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.